Clinical considerations for the diagnosis and treatment of ADHD in the managed care setting.

The American journal of managed care

Volumn 15, Issue 5 Suppl, 2009, Pages

  Jensen, Peter S ^a  

^a REsource for Advancing Children's Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR AFFECTING AGENT; ATOMOXETINE; CENTRAL STIMULANT AGENT; DEXAMPHETAMINE; DOPAMINE UPTAKE INHIBITOR; METHYLPHENIDATE; PROPYLAMINE;

ATTENTION DEFICIT DISORDER; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; HEALTH INSURANCE; HUMAN; REVIEW;

ADRENERGIC UPTAKE INHIBITORS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; DEXTROAMPHETAMINE; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DOPAMINE UPTAKE INHIBITORS; HUMANS; MANAGED CARE PROGRAMS; METHYLPHENIDATE; PROPYLAMINES;

EID: 70349759110     PISSN: None     EISSN: 19362692     Source Type: Journal    
DOI: None     Document Type: Review

References (47)